<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39322989</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2060</ISSN><JournalIssue CitedMedium="Internet"><Volume>56</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Annals of medicine</Title><ISOAbbreviation>Ann Med</ISOAbbreviation></Journal><ArticleTitle>Prehospital Pandemic Respiratory Infection Emergency System Triage score can effectively predict the 30-day mortality of COVID-19 patients with pneumonia.</ArticleTitle><Pagination><StartPage>2407954</StartPage><MedlinePgn>2407954</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2407954</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1080/07853890.2024.2407954</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Coronavirus disease 2019 (COVID-19) patients with pneumonia should receive the guidance of initial risk stratification and early warning as soon as possible. Whether the prehospital Pandemic Respiratory Infection Emergency System Triage (PRIEST) score can accurately predict the short-term prognosis of them remains unknown. Accordingly, we aimed to assess the performance of prehospital PRIEST in predicting the 30-day mortality of patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This retrospective study evaluated the accuracy of five physiological parameters scores commonly used in prehospital disposal for mortality prediction using receiver operating characteristic curves and decision curve analysis. Cox proportional hazard regression analysis was conducted to evaluate independent predictors associated with the 30-day mortality.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 231 patients were included in this study, among which 23 cases (10.0%) died within 30 days after admission. Compared with survivor patients, non-survivor patients had greater numbers of comorbidities, signs and symptoms, complications, and physiological parameters scores and required greater prehospital care (<i>p</i> &lt; 0.05). When the PRIEST score was &gt;12, the sensitivity was 91.3%, and the specificity was 77.4%. We found that the area under the curve of the PRIEST score (0.887, <i>p</i> &lt; 0.05) for mortality prediction was greater than that of the quick Sequential Organ Failure Assessment (0.724), CRB-65 (0.780), Rapid Emergency Medicine Score (0.809), and National Early Warning Score 2 (0.838). Moreover, prehospital PRIEST scores were positively correlated with numbers of comorbidities and numbers of prehospital treatment measures. The 30-day survival rate of patients with PRIEST scores ≤12 (98.8%) significantly exceeded that of patients with PRIEST scores &gt;12 (69.1%) (<i>p</i> &lt; 0.001). Prehospital PRIEST scores &gt;12 (HR = 7.409) was one of the independent predictors of the 30-day mortality.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">The PRIEST can accurately, quickly, and conveniently predict the 30-day mortality of COVID-19 patients with pneumonia in the prehospital phase and can guide their initial risk stratification and treatment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Senior Department of Hepatology, The Fifth Medical Center of PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Liang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Senior Department of Hepatology, The Fifth Medical Center of PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Zhao</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Senior Department of Oncology, The Fifth Medical Center of PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Junyuan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Medical Service Department, The Fifth Medical Center of PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jia</LastName><ForeName>Xiaodong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Senior Department of Oncology, The Fifth Medical Center of PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Kaili</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Senior Department of Hepatology, The Fifth Medical Center of PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Haibin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Senior Department of Hepatology, The Fifth Medical Center of PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ann Med</MedlineTA><NlmUniqueID>8906388</NlmUniqueID><ISSNLinking>0785-3890</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014218" MajorTopicYN="Y">Triage</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004632" MajorTopicYN="Y">Emergency Medical Services</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Coronavirus disease 2019</Keyword><Keyword MajorTopicYN="N">Pandemic Respiratory Infection Emergency System Triage</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">physiological parameters</Keyword><Keyword MajorTopicYN="N">prehospital</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>10</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>0</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39322989</ArticleId><ArticleId IdType="pmc">PMC11425689</ArticleId><ArticleId IdType="doi">10.1080/07853890.2024.2407954</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>National Institutes of Health . Coronavirus disease 2019 (COVID-19) treatment guidelines. Clinical Spectrum. Available from: https://www.covid19treatmentguidelines.nih.gov/</Citation><ArticleIdList><ArticleId IdType="pubmed">34003615</ArticleId></ArticleIdList></Reference><Reference><Citation>Minh LHN, Abozaid AA, Ha NX, et al. . Clinical and laboratory factors associated with coronavirus disease 2019 (Covid-19): a systematic review and meta-analysis. Rev Med Virol. 2021;31(6):e2288. doi: 10.1002/rmv.2288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2288</ArticleId><ArticleId IdType="pmc">PMC8646520</ArticleId><ArticleId IdType="pubmed">34472152</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu X, Hu C, Yang Y, et al. . Clinical characteristics and risk factors for severity of COVID-19 outside Wuhan: a double-center retrospective cohort study of 213 cases in Hunan, China. Ther Adv Respir Dis. 2020;14:1753466620963035. doi: 10.1177/1753466620963035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1753466620963035</ArticleId><ArticleId IdType="pmc">PMC7649871</ArticleId><ArticleId IdType="pubmed">33138694</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, Peng Y, Wu X, et al. . Comorbidities and complications of COVID-19 associated with disease severity, progression, and mortality in China with centralized isolation and hospitalization: a systematic review and meta-analysis. Front Public Health. 2022;10:923485. doi: 10.3389/fpubh.2022.923485.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.923485</ArticleId><ArticleId IdType="pmc">PMC9424916</ArticleId><ArticleId IdType="pubmed">36052001</ArticleId></ArticleIdList></Reference><Reference><Citation>Verveen A, Wynberg E, van Willigen HDG, et al. . Health-related quality of life among persons with initial mild, moderate, and severe or critical COVID-19 at 1 and 12 months after infection: a prospective cohort study. BMC Med. 2022;20(1):422. doi: 10.1186/s12916-022-02615-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02615-7</ArticleId><ArticleId IdType="pmc">PMC9629769</ArticleId><ArticleId IdType="pubmed">36324167</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C, Wang K, Wu L, et al. . Prehospital physiological parameters related illness severity scores can accurately discriminate the severe/critical state in adult patients with COVID-19. Ann Med. 2023;55(2):2239829.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10392258</ArticleId><ArticleId IdType="pubmed">37489620</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Zhang Y, Duan W, et al. . Using an influenza surveillance system to estimate the number of SARS-CoV-2 infections in Beijing, China, weeks 2 to 6 2023. Euro Surveill. 2023;28(11):2300128. doi: 10.2807/1560-7917.ES.2023.28.11.2300128.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2023.28.11.2300128</ArticleId><ArticleId IdType="pmc">PMC10021470</ArticleId><ArticleId IdType="pubmed">36927716</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng L, Bai WH, Yang JJ, et al. . Construction and validation of mortality risk nomograph model for severe/critical patients with COVID-19. Diagnostics (Basel). 2022;12(10):2562. doi: 10.3390/diagnostics12102562.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics12102562</ArticleId><ArticleId IdType="pmc">PMC9601583</ArticleId><ArticleId IdType="pubmed">36292251</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, Xia W, Miao S, et al. . Clinical characteristics of severe COVID-19 patients during omicron epidemic and a nomogram model integrating cell-free DNA for predicting mortality: a retrospective analysis. Infect Drug Resist. 2023;16:6735–6745. doi: 10.2147/IDR.S430101.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S430101</ArticleId><ArticleId IdType="pmc">PMC10590600</ArticleId><ArticleId IdType="pubmed">37873032</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong GY, Jin FF, Huang Q, et al. . Exploratory COVID-19 death risk score based on basic laboratory tests and physiological clinical measurements. World J Emerg Med. 2022;13(6):453–458. doi: 10.5847/wjem.j.1920-8642.2022.103.</Citation><ArticleIdList><ArticleId IdType="doi">10.5847/wjem.j.1920-8642.2022.103</ArticleId><ArticleId IdType="pmc">PMC9807385</ArticleId><ArticleId IdType="pubmed">36636572</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu FY, Sun XL, Zhang Y, et al. . Evaluation of the risk prediction tools for patients with coronavirus disease 2019 in Wuhan, China: a single-centered, retrospective, observational study. Crit Care Med. 2020;48(11):e1004-11–e1011. doi: 10.1097/CCM.0000000000004549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004549</ArticleId><ArticleId IdType="pmc">PMC7448719</ArticleId><ArticleId IdType="pubmed">32897668</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodacre S, Thomas B, Sutton L, et al. . Derivation and validation of a clinical severity score for acutely ill adults with suspected COVID-19: the PRIEST observational cohort study. PLoS One. 2021;16(1):e0245840. doi: 10.1371/journal.pone.0245840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0245840</ArticleId><ArticleId IdType="pmc">PMC7822515</ArticleId><ArticleId IdType="pubmed">33481930</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, et al. . The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–810. doi: 10.1001/jama.2016.0287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsson T, Lind L.. Comparison of the Rapid Emergency Medicine Score and APACHE II in nonsurgical ­emergency department patients. Acad Emerg Med. 2003;10(10):1040–1048. doi: 10.1197/S1069-6563(03)00342-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1197/S1069-6563(03)00342-7</ArticleId><ArticleId IdType="pubmed">14525735</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim WS, van der Eerden MM, Laing R, et al. . Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377–382. doi: 10.1136/thorax.58.5.377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thorax.58.5.377</ArticleId><ArticleId IdType="pmc">PMC1746657</ArticleId><ArticleId IdType="pubmed">12728155</ArticleId></ArticleIdList></Reference><Reference><Citation>Royal College of Physicians . 2017. National Early Warning Score (NEWS) 2. Available from: https://www.rcplondon.ac.uk/projects/outputs/national-early-warning-score-news-2</Citation></Reference><Reference><Citation>Chávez-Ocaña SDC, Bravata-Alcántara JC, Cortés-Ortiz IA, et al. . Parameters to predict the outcome of severe and critical COVID-19 patients when admitted to the hospital. J Clin Med. 2023;12(4):1323. doi: 10.3390/jcm12041323.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12041323</ArticleId><ArticleId IdType="pmc">PMC9959673</ArticleId><ArticleId IdType="pubmed">36835858</ArticleId></ArticleIdList></Reference><Reference><Citation>Heydari F, Zamani M, Masoumi B, et al. . Physiologic scoring systems in predicting the COVID-19 patients’ one-month mortality; a prognostic accuracy study. Arch Acad Emerg Med. 2022;10(1):e83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9676706</ArticleId><ArticleId IdType="pubmed">36426162</ArticleId></ArticleIdList></Reference><Reference><Citation>Buttia C, Llanaj E, Raeisi-Dehkordi H, et al. . Prognostic models in COVID-19 infection that predict severity: a systematic review. Eur J Epidemiol. 2023;38(4):355–372. doi: 10.1007/s10654-023-00973-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-023-00973-x</ArticleId><ArticleId IdType="pmc">PMC9958330</ArticleId><ArticleId IdType="pubmed">36840867</ArticleId></ArticleIdList></Reference><Reference><Citation>Casillas N, Ramón A, Torres AM, et al. . Predictive model for mortality in severe COVID-19 patients across the six pandemic waves. Viruses. 2023;15(11):2184. doi: 10.3390/v15112184.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15112184</ArticleId><ArticleId IdType="pmc">PMC10675561</ArticleId><ArticleId IdType="pubmed">38005862</ArticleId></ArticleIdList></Reference><Reference><Citation>Tana C, Ricci F, Coppola MG, et al. . Prognostic significance of chest imaging by LUS and CT in COVID-19 inpatients: the ECOVID multicenter study. Respiration. 2022;101(2):122–131. doi: 10.1159/000518516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000518516</ArticleId><ArticleId IdType="pmc">PMC8450833</ArticleId><ArticleId IdType="pubmed">34515247</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu J, Hua L, Liu X, et al. . Superoxide dismutase alterations in COVID-19: implications for disease severity and mortality prediction in the context of omicron variant infection. Front Immunol. 2024;15:1362102. doi: 10.3389/fimmu.2024.1362102.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2024.1362102</ArticleId><ArticleId IdType="pmc">PMC10921560</ArticleId><ArticleId IdType="pubmed">38464514</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallari CT, Achilleos S, Quattrocchi A, et al. . Magnitude and determinants of excess total, age-specific and sex-specific all-cause mortality in 24 countries worldwide during 2020 and 2021: results on the impact of the COVID-19 pandemic from the C-MOR project. BMJ Glob Health. 2024;9(4):e013018. doi: 10.1136/bmjgh-2023-013018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2023-013018</ArticleId><ArticleId IdType="pmc">PMC11029481</ArticleId><ArticleId IdType="pubmed">38637119</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X, Li C, Yuan X, et al. . Associations of nirmatrelvir-ritonavir treatment with death and clinical improvement in hospitalized patients with COVID-19 during the Omicron wave in Beijing, China: a multicentre, retrospective cohort study. Ann Med. 2024;56(1):2313062.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10868413</ArticleId><ArticleId IdType="pubmed">38354691</ArticleId></ArticleIdList></Reference><Reference><Citation>Elezkurtaj S, Greuel S, Ihlow J, et al. . Causes of death and comorbidities in hospitalized patients with COVID-19. Sci Rep. 2021;11(1):4263. doi: 10.1038/s41598-021-82862-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-82862-5</ArticleId><ArticleId IdType="pmc">PMC7895917</ArticleId><ArticleId IdType="pubmed">33608563</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman SN.. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open. 2021;4(5):e2111417. doi: 10.1001/jamanetworkopen.2021.11417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Alizadehsani R, Alizadeh Sani Z, Behjati M, et al. . Risk factors prediction, clinical outcomes, and mortality in COVID-19 patients. J Med Virol. 2021;93(4):2307–2320. doi: 10.1002/jmv.26699.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26699</ArticleId><ArticleId IdType="pmc">PMC7753243</ArticleId><ArticleId IdType="pubmed">33247599</ArticleId></ArticleIdList></Reference><Reference><Citation>Vedovati MC, Barbieri G, Urbini C, et al. . Clinical prediction models in hospitalized patients with COVID-19: a multicenter cohort study. Respir Med. 2022;202:106954. doi: 10.1016/j.rmed.2022.106954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2022.106954</ArticleId><ArticleId IdType="pmc">PMC9392655</ArticleId><ArticleId IdType="pubmed">36057141</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan G, Tu C, Zhou F, et al. . Comparison of severity scores for COVID-19 patients with pneumonia: a retrospective study. Eur Respir J. 2020;56(3):2002113. doi: 10.1183/13993003.02113-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02113-2020</ArticleId><ArticleId IdType="pmc">PMC7366179</ArticleId><ArticleId IdType="pubmed">32675205</ArticleId></ArticleIdList></Reference><Reference><Citation>Marincowitz C, Sutton L, Stone T, et al. . Prognostic accuracy of triage tools for adults with suspected COVID-19 in a prehospital setting: an observational cohort study. Emerg Med J. 2022;39(4):317–324. doi: 10.1136/emermed-2021-211934.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/emermed-2021-211934</ArticleId><ArticleId IdType="pmc">PMC8844966</ArticleId><ArticleId IdType="pubmed">35140074</ArticleId></ArticleIdList></Reference><Reference><Citation>Marincowitz C, Sbaffi L, Hasan M, et al. . External validation of triage tools for adults with suspected COVID-19 in a middle-income setting: an observational cohort study. Emerg Med J. 2023;40(7):509–517. doi: 10.1136/emermed-2022-212827.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/emermed-2022-212827</ArticleId><ArticleId IdType="pmc">PMC10359554</ArticleId><ArticleId IdType="pubmed">37217302</ArticleId></ArticleIdList></Reference><Reference><Citation>Paraskevas T, Michailides C, Karalis I, et al. . External validation of the 4C Mortality Score and PRIEST COVID-19 Clinical Severity Score in patients hospitalized with COVID-19 pneumonia in Greece. Rom J Intern Med. 2022;60(4):244–249. doi: 10.2478/rjim-2022-0015.</Citation><ArticleIdList><ArticleId IdType="doi">10.2478/rjim-2022-0015</ArticleId><ArticleId IdType="pubmed">36153740</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas B, Goodacre S, Lee E, et al. . Prognostic accuracy of emergency department triage tools for adults with suspected COVID-19: the PRIEST observational cohort study. Emerg Med J. 2021;38(8):587–593. doi: 10.1136/emermed-2020-210783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/emermed-2020-210783</ArticleId><ArticleId IdType="pmc">PMC8182747</ArticleId><ArticleId IdType="pubmed">34083427</ArticleId></ArticleIdList></Reference><Reference><Citation>Gattinoni L, Gattarello S, Steinberg I, et al. . COVID-19 pneumonia: pathophysiology and management. Eur Respir Rev. 2021;30(162):210138. doi: 10.1183/16000617.0138-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/16000617.0138-2021</ArticleId><ArticleId IdType="pmc">PMC8527244</ArticleId><ArticleId IdType="pubmed">34670808</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>